Working… Menu
Trial record 1 of 1 for:    ileukpulm
Previous Study | Return to List | Next Study

Study of Sargramostim in Patients With COVID-19 (iLeukPulm)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04411680
Recruitment Status : Completed
First Posted : June 2, 2020
Last Update Posted : June 21, 2021
United States Department of Defense
Information provided by (Responsible Party):
Partner Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 2, 2021
Actual Study Completion Date : May 19, 2021